Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Hematology
•
Sickle Cell
•
Plasma exchange
•
Benign Hematology
•
Hospital Medicine
Would you ever consider depleting alloantibodies using plasma exchange to allow for partially matched RBC exchange in sickle cell patients with critically severe acute chest?
Related Questions
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
What are your top takeaways in Classical Hematology from ASH 2024?
What is your approach to optimizing pre-operative hemoglobin in patients with sickle cell disease?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
Do you routinely screen and replace Vitamin D in patients with ITP?
Would you consider a positive DAT and indirect Coombs test, persistent and consistent with IgG warm antibody, clinically significant in absence of hemolysis?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?
How would you manage iron overload in sickle cell patients with cirrhosis?
Given the data from SWOG 1826 suggesting that Nivo-AVD is likely the preferred regimen for advanced Hodgkin lymphoma patients, are there scenarios where alternative regimens may still be preferred?
